Reviva Pharmaceuticals RVPH Q1 2026 Earnings EPS Beats Estimates as Cost Discipline Drives SmallerThanExpected Loss COCP Q1 2026 Earnings WiderThanExpected Loss Weighs on EarlyStage Biotech Riskified Ltd RSKD Q1 2026 Earnings Strong EPS Beat Driven by Operational Discipline Assurant Inc AIZ Q1 2026 Earnings Strong EPS Beat Amid Flat Revenue and Modest Stock Decline Huntington Ingalls Industries Inc HII Q1 2026 Earnings Adjusted EPS Slightly Beats Estimates Amid Robust Defense Demand PCVX Q1 2026 Earnings Missed Estimates Amid PreRevenue Stage Stock Inches Higher